08:00 , Dec 10, 2007 |  BC Week In Review  |  Company News

Binex, MaxCyte deal

The companies will evaluate MaxCyte's cell-loading technology for manufacturing Binex's cell-based cancer immunotherapies. Binex, which is funding the work, has two dendritic cell immunotherapies under review in Korea to treat colorectal cancer and non-small cell...